627P Phase II neoadjuvant trial of the anti–B7-H3 antibody, enoblituzumab, in men with localized prostate cancer: Safety, efficacy and immune correlates
| Autor: | Shenderov, E., De Marzo, A., Lotan, T., Wang, H., Allaf, M.E., Boudadi, K., Chapman, C., O'Neal, T., Chen, F., Moore, P., Muth, J., Sorg, K., White, A.M., Church, S.E., Bivalacqua, T., Ross, A.E., Pavlovich, C.P., Drake, C.G., Pardoll, D., Antonarakis, E.S. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S662-S663 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|